Structure

Physi-Chem Properties

Molecular Weight:  538.16
Volume:  544.101
LogP:  6.831
LogD:  3.746
LogS:  -6.612
# Rotatable Bonds:  5
TPSA:  117.84
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.177
Synthetic Accessibility Score:  2.772
Fsp3:  0.125
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.912
MDCK Permeability:  4.02741388825234e-05
Pgp-inhibitor:  0.206
Pgp-substrate:  0.052
Human Intestinal Absorption (HIA):  0.775
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.598

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  74.7582015991211%
Volume Distribution (VD):  0.398
Pgp-substrate:  11.598455429077148%

ADMET: Metabolism

CYP1A2-inhibitor:  0.767
CYP1A2-substrate:  0.907
CYP2C19-inhibitor:  0.597
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.666
CYP2C9-substrate:  0.93
CYP2D6-inhibitor:  0.024
CYP2D6-substrate:  0.918
CYP3A4-inhibitor:  0.168
CYP3A4-substrate:  0.129

ADMET: Excretion

Clearance (CL):  6.319
Half-life (T1/2):  0.137

ADMET: Toxicity

hERG Blockers:  0.072
Human Hepatotoxicity (H-HT):  0.043
Drug-inuced Liver Injury (DILI):  0.981
AMES Toxicity:  0.706
Rat Oral Acute Toxicity:  0.309
Maximum Recommended Daily Dose:  0.935
Skin Sensitization:  0.921
Carcinogencity:  0.529
Eye Corrosion:  0.003
Eye Irritation:  0.937
Respiratory Toxicity:  0.275

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC126291

Natural Product ID:  NPC126291
Common Name*:   PHYSWDUDIPIMOO-UHFFFAOYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  PHYSWDUDIPIMOO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C32H26O8/c1-37-25-13-23(35)29(19-7-5-17-15(27(19)25)9-11-21(33)31(17)39-3)30-20-8-6-18-16(10-12-22(34)32(18)40-4)28(20)26(38-2)14-24(30)36/h5-14,33-36H,1-4H3
SMILES:  COc1cc(O)c(c2c1c1ccc(c(c1cc2)OC)O)c1c(O)cc(c2c1ccc1c2ccc(c1OC)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581376
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives
        • [CHEMONTID:0003007] Phenanthrols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[15686910]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota Fibrous Roots n.a. n.a. PMID[25760525]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[31415170]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO10780 Bletilla striata Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 = 1000.0 nM PMID[558498]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 8.0 ug.mL-1 PMID[558497]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 16.0 ug.mL-1 PMID[558497]
NPT1204 Organism Enterococcus faecalis ATCC 29212 Enterococcus faecalis ATCC 29212 MIC = 64.0 ug.mL-1 PMID[558497]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 8.0 ug.mL-1 PMID[558497]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 8.0 ug.mL-1 PMID[558497]
NPT19 Organism Escherichia coli Escherichia coli MIC > 128.0 ug.mL-1 PMID[558497]
NPT766 Organism Proteus vulgaris Proteus vulgaris MIC > 128.0 ug.mL-1 PMID[558497]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC126291 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9786 High Similarity NPC262297
0.9568 High Similarity NPC183709
0.9429 High Similarity NPC472087
0.9429 High Similarity NPC472088
0.9424 High Similarity NPC308768
0.9424 High Similarity NPC12668
0.9357 High Similarity NPC472089
0.9353 High Similarity NPC218131
0.9353 High Similarity NPC105847
0.9353 High Similarity NPC220344
0.9353 High Similarity NPC243996
0.9353 High Similarity NPC275061
0.9353 High Similarity NPC243759
0.9353 High Similarity NPC132804
0.9348 High Similarity NPC30632
0.9291 High Similarity NPC175838
0.9286 High Similarity NPC472092
0.9286 High Similarity NPC273623
0.9286 High Similarity NPC472090
0.9286 High Similarity NPC472091
0.9281 High Similarity NPC266006
0.9281 High Similarity NPC22902
0.9281 High Similarity NPC56329
0.9281 High Similarity NPC151656
0.9281 High Similarity NPC242715
0.9281 High Similarity NPC200935
0.9281 High Similarity NPC71465
0.9281 High Similarity NPC266453
0.9281 High Similarity NPC230919
0.9281 High Similarity NPC472646
0.9275 High Similarity NPC241241
0.9209 High Similarity NPC472647
0.9209 High Similarity NPC133463
0.9209 High Similarity NPC472649
0.9209 High Similarity NPC202846
0.9209 High Similarity NPC170328
0.9209 High Similarity NPC206525
0.9209 High Similarity NPC472648
0.9209 High Similarity NPC143139
0.9209 High Similarity NPC191462
0.9149 High Similarity NPC295719
0.9149 High Similarity NPC165026
0.9149 High Similarity NPC34431
0.9149 High Similarity NPC73505
0.9137 High Similarity NPC294884
0.9137 High Similarity NPC258780
0.9137 High Similarity NPC158142
0.9137 High Similarity NPC10314
0.9137 High Similarity NPC37410
0.9137 High Similarity NPC200557
0.9137 High Similarity NPC69029
0.9137 High Similarity NPC108198
0.9078 High Similarity NPC29868
0.9078 High Similarity NPC79622
0.9078 High Similarity NPC212942
0.9065 High Similarity NPC160697
0.9065 High Similarity NPC125649
0.9058 High Similarity NPC303144
0.9054 High Similarity NPC476391
0.9007 High Similarity NPC90615
0.9007 High Similarity NPC73535
0.9007 High Similarity NPC272157
0.9007 High Similarity NPC25111
0.9007 High Similarity NPC6262
0.9007 High Similarity NPC201145
0.9 High Similarity NPC313081
0.898 High Similarity NPC321657
0.898 High Similarity NPC318373
0.898 High Similarity NPC476969
0.8973 High Similarity NPC174251
0.8973 High Similarity NPC153182
0.8944 High Similarity NPC230124
0.8944 High Similarity NPC184613
0.8944 High Similarity NPC6300
0.8944 High Similarity NPC55947
0.8944 High Similarity NPC114171
0.8936 High Similarity NPC114155
0.8936 High Similarity NPC300846
0.8936 High Similarity NPC205442
0.8936 High Similarity NPC476639
0.8933 High Similarity NPC157333
0.8921 High Similarity NPC228843
0.8919 High Similarity NPC477612
0.8904 High Similarity NPC274454
0.8904 High Similarity NPC215678
0.8889 High Similarity NPC277784
0.8865 High Similarity NPC283009
0.8865 High Similarity NPC111655
0.8865 High Similarity NPC261873
0.8851 High Similarity NPC211561
0.8849 High Similarity NPC282508
0.8849 High Similarity NPC149337
0.8849 High Similarity NPC471983
0.8794 High Similarity NPC209199
0.8794 High Similarity NPC103967
0.8786 High Similarity NPC161958
0.8786 High Similarity NPC14224
0.8777 High Similarity NPC126836
0.8777 High Similarity NPC254000
0.8776 High Similarity NPC233980
0.8776 High Similarity NPC150714
0.8776 High Similarity NPC95652
0.8759 High Similarity NPC470917
0.875 High Similarity NPC22317
0.875 High Similarity NPC20520
0.875 High Similarity NPC61783
0.875 High Similarity NPC202104
0.8732 High Similarity NPC256262
0.8723 High Similarity NPC32778
0.8716 High Similarity NPC204770
0.8716 High Similarity NPC263940
0.8716 High Similarity NPC18185
0.8716 High Similarity NPC170103
0.8716 High Similarity NPC474397
0.8716 High Similarity NPC82917
0.8716 High Similarity NPC108811
0.8716 High Similarity NPC202742
0.8716 High Similarity NPC262911
0.8716 High Similarity NPC294558
0.8716 High Similarity NPC236202
0.8716 High Similarity NPC58190
0.8716 High Similarity NPC70409
0.8714 High Similarity NPC15543
0.8699 High Similarity NPC469630
0.869 High Similarity NPC265075
0.8675 High Similarity NPC226809
0.8675 High Similarity NPC279406
0.8667 High Similarity NPC205501
0.8667 High Similarity NPC162976
0.8667 High Similarity NPC118000
0.8662 High Similarity NPC141023
0.8662 High Similarity NPC206737
0.8662 High Similarity NPC7515
0.8662 High Similarity NPC469659
0.8662 High Similarity NPC66840
0.8662 High Similarity NPC289258
0.8662 High Similarity NPC256307
0.8662 High Similarity NPC276026
0.8662 High Similarity NPC56764
0.8662 High Similarity NPC188378
0.8662 High Similarity NPC555
0.8658 High Similarity NPC227516
0.8658 High Similarity NPC281549
0.8658 High Similarity NPC20757
0.8652 High Similarity NPC218884
0.8649 High Similarity NPC96576
0.8639 High Similarity NPC171932
0.8639 High Similarity NPC304894
0.8639 High Similarity NPC15659
0.8639 High Similarity NPC469795
0.8639 High Similarity NPC473108
0.8639 High Similarity NPC28440
0.8633 High Similarity NPC38017
0.8633 High Similarity NPC23012
0.8633 High Similarity NPC215300
0.8633 High Similarity NPC28765
0.8633 High Similarity NPC154866
0.8621 High Similarity NPC262189
0.8621 High Similarity NPC266650
0.8618 High Similarity NPC224161
0.8611 High Similarity NPC48956
0.8601 High Similarity NPC55239
0.8601 High Similarity NPC180602
0.8601 High Similarity NPC214853
0.8601 High Similarity NPC240279
0.8582 High Similarity NPC471517
0.8582 High Similarity NPC473309
0.8571 High Similarity NPC163508
0.8571 High Similarity NPC173203
0.8571 High Similarity NPC471518
0.8571 High Similarity NPC471519
0.8562 High Similarity NPC46335
0.8561 High Similarity NPC293054
0.8561 High Similarity NPC169474
0.8561 High Similarity NPC21563
0.8561 High Similarity NPC53781
0.8561 High Similarity NPC266555
0.8561 High Similarity NPC471986
0.8561 High Similarity NPC246620
0.8561 High Similarity NPC236760
0.8561 High Similarity NPC124452
0.8561 High Similarity NPC324112
0.8561 High Similarity NPC252131
0.8561 High Similarity NPC74817
0.8561 High Similarity NPC282000
0.8561 High Similarity NPC159968
0.8561 High Similarity NPC82679
0.8561 High Similarity NPC236791
0.8553 High Similarity NPC21902
0.8553 High Similarity NPC157783
0.8552 High Similarity NPC70682
0.8552 High Similarity NPC260741
0.8552 High Similarity NPC22517
0.8552 High Similarity NPC32630
0.8542 High Similarity NPC133025
0.8533 High Similarity NPC329836
0.8531 High Similarity NPC311256
0.8523 High Similarity NPC260397
0.8523 High Similarity NPC112251
0.8521 High Similarity NPC73656

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC126291 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.831 Intermediate Similarity NPD3027 Phase 3
0.8112 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD6232 Discontinued
0.8056 Intermediate Similarity NPD4625 Phase 3
0.8042 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD1613 Approved
0.8 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7473 Discontinued
0.7862 Intermediate Similarity NPD4908 Phase 1
0.7791 Intermediate Similarity NPD6959 Discontinued
0.7778 Intermediate Similarity NPD6234 Discontinued
0.7725 Intermediate Similarity NPD5844 Phase 1
0.7688 Intermediate Similarity NPD37 Approved
0.7688 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7671 Intermediate Similarity NPD3018 Phase 2
0.7665 Intermediate Similarity NPD7228 Approved
0.7597 Intermediate Similarity NPD6674 Discontinued
0.7558 Intermediate Similarity NPD8053 Approved
0.7558 Intermediate Similarity NPD8054 Approved
0.7546 Intermediate Similarity NPD4965 Approved
0.7546 Intermediate Similarity NPD4966 Approved
0.7546 Intermediate Similarity NPD4967 Phase 2
0.7545 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD6166 Phase 2
0.7533 Intermediate Similarity NPD3620 Phase 2
0.7533 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD2983 Phase 2
0.7517 Intermediate Similarity NPD2982 Phase 2
0.7516 Intermediate Similarity NPD7390 Discontinued
0.7484 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD2981 Phase 2
0.7442 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD1465 Phase 2
0.7423 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD4749 Approved
0.7397 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD1610 Phase 2
0.7365 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD7199 Phase 2
0.7362 Intermediate Similarity NPD1934 Approved
0.7358 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7357 Intermediate Similarity NPD5283 Phase 1
0.7338 Intermediate Similarity NPD228 Approved
0.7326 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD2801 Approved
0.7303 Intermediate Similarity NPD4060 Phase 1
0.7285 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD7768 Phase 2
0.7222 Intermediate Similarity NPD1548 Phase 1
0.7215 Intermediate Similarity NPD7003 Approved
0.7212 Intermediate Similarity NPD8455 Phase 2
0.7208 Intermediate Similarity NPD4097 Suspended
0.7184 Intermediate Similarity NPD7240 Approved
0.7168 Intermediate Similarity NPD7074 Phase 3
0.7162 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD8099 Discontinued
0.7151 Intermediate Similarity NPD8251 Approved
0.7151 Intermediate Similarity NPD8252 Approved
0.7143 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD3540 Phase 1
0.7134 Intermediate Similarity NPD4380 Phase 2
0.7123 Intermediate Similarity NPD4626 Approved
0.7117 Intermediate Similarity NPD1653 Approved
0.7114 Intermediate Similarity NPD6696 Suspended
0.711 Intermediate Similarity NPD8156 Discontinued
0.711 Intermediate Similarity NPD7054 Approved
0.7102 Intermediate Similarity NPD8313 Approved
0.7102 Intermediate Similarity NPD8312 Approved
0.7086 Intermediate Similarity NPD2861 Phase 2
0.7083 Intermediate Similarity NPD4055 Discovery
0.7081 Intermediate Similarity NPD1511 Approved
0.7073 Intermediate Similarity NPD4005 Discontinued
0.7071 Intermediate Similarity NPD3022 Approved
0.7071 Intermediate Similarity NPD3021 Approved
0.707 Intermediate Similarity NPD3539 Phase 1
0.7069 Intermediate Similarity NPD7472 Approved
0.7066 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD2342 Discontinued
0.7039 Intermediate Similarity NPD7906 Approved
0.7037 Intermediate Similarity NPD7447 Phase 1
0.7027 Intermediate Similarity NPD3705 Approved
0.7025 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD3882 Suspended
0.7022 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7819 Suspended
0.7005 Intermediate Similarity NPD7680 Approved
0.7 Intermediate Similarity NPD8166 Discontinued
0.7 Intermediate Similarity NPD8651 Approved
0.6994 Remote Similarity NPD1512 Approved
0.6994 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6994 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6993 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6559 Discontinued
0.6982 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6975 Remote Similarity NPD7212 Phase 2
0.6975 Remote Similarity NPD7040 Clinical (unspecified phase)
0.6975 Remote Similarity NPD7213 Phase 3
0.6975 Remote Similarity NPD7041 Phase 2
0.6964 Remote Similarity NPD3817 Phase 2
0.6962 Remote Similarity NPD6100 Approved
0.6962 Remote Similarity NPD5408 Approved
0.6962 Remote Similarity NPD5404 Approved
0.6962 Remote Similarity NPD5406 Approved
0.6962 Remote Similarity NPD5405 Approved
0.6962 Remote Similarity NPD6099 Approved
0.6957 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6954 Remote Similarity NPD3818 Discontinued
0.6951 Remote Similarity NPD6980 Clinical (unspecified phase)
0.695 Remote Similarity NPD4750 Phase 3
0.6949 Remote Similarity NPD7808 Phase 3
0.6949 Remote Similarity NPD7549 Discontinued
0.6939 Remote Similarity NPD1651 Approved
0.6933 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6932 Remote Similarity NPD6797 Phase 2
0.6923 Remote Similarity NPD7635 Approved
0.6923 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6919 Remote Similarity NPD7229 Phase 3
0.6919 Remote Similarity NPD3787 Discontinued
0.6918 Remote Similarity NPD7266 Discontinued
0.6911 Remote Similarity NPD8151 Discontinued
0.6901 Remote Similarity NPD5494 Approved
0.6894 Remote Similarity NPD3750 Approved
0.6893 Remote Similarity NPD7251 Discontinued
0.6887 Remote Similarity NPD1283 Approved
0.6882 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6872 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6871 Remote Similarity NPD6143 Clinical (unspecified phase)
0.686 Remote Similarity NPD8127 Discontinued
0.6859 Remote Similarity NPD1558 Phase 1
0.6842 Remote Similarity NPD3094 Phase 2
0.6839 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6829 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6829 Remote Similarity NPD2533 Approved
0.6829 Remote Similarity NPD2534 Approved
0.6829 Remote Similarity NPD2532 Approved
0.6824 Remote Similarity NPD5691 Approved
0.6818 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6816 Remote Similarity NPD4578 Approved
0.6816 Remote Similarity NPD4577 Approved
0.6816 Remote Similarity NPD7312 Approved
0.6816 Remote Similarity NPD7311 Approved
0.6816 Remote Similarity NPD7310 Approved
0.6816 Remote Similarity NPD7313 Approved
0.6815 Remote Similarity NPD5735 Approved
0.6815 Remote Similarity NPD3657 Discovery
0.681 Remote Similarity NPD7124 Phase 2
0.68 Remote Similarity NPD1611 Approved
0.6797 Remote Similarity NPD4624 Approved
0.6796 Remote Similarity NPD4663 Approved
0.679 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6786 Remote Similarity NPD7411 Suspended
0.6784 Remote Similarity NPD7075 Discontinued
0.6784 Remote Similarity NPD7832 Clinical (unspecified phase)
0.6784 Remote Similarity NPD7831 Phase 2
0.6784 Remote Similarity NPD7833 Phase 2
0.6778 Remote Similarity NPD7309 Approved
0.6772 Remote Similarity NPD1607 Approved
0.677 Remote Similarity NPD7037 Approved
0.6768 Remote Similarity NPD4357 Discontinued
0.6766 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7458 Discontinued
0.676 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6759 Remote Similarity NPD1398 Phase 1
0.675 Remote Similarity NPD2438 Suspended
0.675 Remote Similarity NPD2935 Discontinued
0.6743 Remote Similarity NPD27 Approved
0.6743 Remote Similarity NPD2489 Approved
0.6735 Remote Similarity NPD7340 Approved
0.6731 Remote Similarity NPD5111 Phase 2
0.6731 Remote Similarity NPD5109 Approved
0.6731 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6731 Remote Similarity NPD5110 Phase 2
0.673 Remote Similarity NPD4536 Approved
0.673 Remote Similarity NPD4537 Clinical (unspecified phase)
0.673 Remote Similarity NPD4538 Approved
0.6728 Remote Similarity NPD5177 Phase 3
0.6727 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6726 Remote Similarity NPD4678 Approved
0.6726 Remote Similarity NPD4675 Approved
0.6725 Remote Similarity NPD6788 Approved
0.6725 Remote Similarity NPD4581 Clinical (unspecified phase)
0.6724 Remote Similarity NPD3051 Approved
0.6711 Remote Similarity NPD1669 Approved
0.6709 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6709 Remote Similarity NPD5124 Phase 1
0.6708 Remote Similarity NPD5763 Approved
0.6708 Remote Similarity NPD5762 Approved
0.6706 Remote Similarity NPD5929 Approved
0.6705 Remote Similarity NPD6746 Phase 2
0.6691 Remote Similarity NPD940 Approved
0.6691 Remote Similarity NPD846 Approved
0.669 Remote Similarity NPD7843 Approved
0.6689 Remote Similarity NPD1281 Approved
0.6689 Remote Similarity NPD5536 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data